Medfield Diagnostics AB (publ)

NGM:MEDF 株式レポート

時価総額：SEK 23.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Medfield Diagnostics マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Bjorn Larsson

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間1.3yrs

経営陣の近況

Recent updates

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

May 12
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Deliver On Growth Plans?

Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Dec 29
Is Medfield Diagnostics (NGM:MEDF) In A Good Position To Invest In Growth?

Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

Sep 07
Companies Like Medfield Diagnostics (NGM:MEDF) Are In A Position To Invest In Growth

CEO（最高経営責任者

Bjorn Larsson

less than a year

在職期間

Mr. Björn Larsson served as Chief Executive Officer at RLS Global AB (publ) since October 01, 2022 until July 2023 and was its Member of Management Board since 2022 until July 2023. He serves as Chief Exec...

取締役

名称ポジション在職期間報酬所有権
Bjorn Larsson
CEO & Director1.8yrsデータなしデータなし
Wigge Jacobsson
Directorno dataSEK 58.35k0.0096%
SEK 2.3k
Mats Andersson
Chairman of the Boardless than a yearデータなし0.0013%
SEK 297.9
Goran Roos
Independent Director1.8yrsデータなしデータなし
Mikael Elam
Directorless than a yearデータなし0.020%
SEK 4.6k

1.3yrs

平均在職期間

経験豊富なボード: MEDFの 取締役会 は 経験豊富 ではない ( 1.3年の平均在任期間) ため、新しい取締役会が必要であると考えられます。